Parker Waichman LLP

Drugs Approved Through Rapid Review Raise Safety Concerns

An expedited review process gets drugs onto the market sooner, but that doesn’t mean that they are as safe as you want them to be. In a study published in JAMA Internal Medicine, lead researcher Thomas Moore and colleagues question whether or not the fast-track review is worth the risks. The study followed 20 drugs […]

fast-track-drugs-safety-dangersAn expedited review process gets drugs onto the market sooner, but that doesn’t mean that they are as safe as you want them to be. In a study published in JAMA Internal Medicine, lead researcher Thomas Moore and colleagues question whether or not the fast-track review is worth the risks. The study followed 20 drugs approved in 2008, 8 of them went through some type of expedited review.

Moore, who is also the senior scientist at the Institute for Safe Medication Practices, said that “Development time and approval of new drugs is really quite rapid, especially for the novel drugs, but a large number of safety questions remain unanswered,” When a drug goes through expedited review, it means that the U.S. Food and Drug Administration (FDA) can waive its own rules as it deems necessary. These drugs are approved in about five years, which is about two and a half years sooner than drugs going through standard review.

The study’s authors found that fast-track drugs were tested in an average of 104 patients, while drugs that went through standard review were tested in about 580 patients. Moore took issue with this, commenting that he was “surprised by how limited some of the testing was,” I think that having poorly tested drugs that we don’t know enough about is of very limited benefit to anybody,” he said.

Overall, five drugs ended up having a boxed warning, which is the most serious kind of warning that can be added to packaging. Four other drugs needed additional precautions on their labeling.  Moore predicts that this will only get worse as time does, noting that the FDA takes about 11 years to act on a safety issue.

The number of post-marketing studies also raised some concerns. A post marketing study is a study that is ordered when there are still a number of safety issues that need to be a addressed for a drug that is on the market. According to the study, the FDA ordered 48 post-marketing studies for the 8 expedited drugs and 37 studies for the 12 standard review drugs. Even more disconcerting is the observed timelines for these. Overall, the authors found that 14 out of the 48 studies that were supposed to be complete by 2013 were unfinished or did not submit for review on time; timelines for six drugs could not be found altogether.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Your staff are the greatest. Words can’t express how satisfied we are for what the staff did to change our lives. Thank you Parker Waichman. Thank you Jerry!
Davie Bush
8 years ago
5 Star Reviews 150
I'm very satisfied with the service I received
Karen Jeffrey
3 years ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value A special thank you to Parker Waichman and Christina Morace for a job well done!!! As the Koreans would say, “Daebek” awesome. Thanks again.
A Ford
2 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038